Drug development

  • AI helps unravel a cause of Alzheimer’s disease and identify a therapeutic candidate

    AI helps unravel a cause of Alzheimer’s disease and identify a therapeutic candidate

    A new study found that a gene recently recognised as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown secondary function - and have used artificial intelligence to help unravel this mystery of Alzheimer’s disease and discover a potential treatment that obstructs the gene’s moonlighting role. About one [...]